Drug Side Effects
Search
MENINGEAL THICKENING
MENINGEAL THICKENING
was reported 19 times
MENINGEAL THICKENING is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Nucleoside Analog Antifungal [EPC]
2
0.0014
1
Amyloid Beta-directed Antibody [EPC]
1
0.0003
2
Lipid-based Polyene Antifungal [EPC]
2
0.0002
3
Asparagine-specific Enzyme [EPC]
1
0.0001
4
Radioligand Therapeutic Agent [EPC]
1
0.0001
5
Polyene Antifungal [EPC]
2
0.0000
6
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
7
Nucleoside Metabolic Inhibitor [EPC]
6
0.0000
8
CTLA-4-directed Blocking Antibody [EPC]
1
0.0000
9
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
10
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
11
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
12
Folate Analog Metabolic Inhibitor [EPC]
6
0.0000
13
Azole Antifungal [EPC]
2
0.0000
14
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
15
Leukocyte Growth Factor [EPC]
1
0.0000
16
Alkylating Drug [EPC]
1
0.0000
17
Corticosteroid [EPC]
5
0.0000
18
Platinum-based Drug [EPC]
1
0.0000
19
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
20
Tumor Necrosis Factor Blocker [EPC]
1
0.0000